BackTowa Pharmaceutical , Ltd. Overview

Towa Pharmaceutical , Ltd. Long Term Debt

Latest long-term debt for TWAPF: $190B.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$194.98B
↓ 6.48% YoYΔ $-13.51B vs prior year quarter

Peer trimmed avg / median

Loading

Towa Pharmaceutical , Ltd. Long Term Debt History

Loading

Towa Pharmaceutical , Ltd. vs. peers: Long Term Debt Comparison

Loading

Towa Pharmaceutical , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Towa Pharmaceutical , Ltd. (TWAPF) FAQ

As of the most recent data (June 2026), TWAPF shows a long-term debt of $190B. That compares with $210B in the prior-year period — down 6.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TWAPF's long-term debt is now $190B (was $210B) — a 6.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Towa Pharmaceutical , Ltd. is outperforming or lagging.

Tracking TWAPF's long-term debt over time shows whether Towa Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $190B That compares with $210B in the prior-year period — down 6.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Towa Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $190B) with ownership activity and broader fundamentals.